最近在治疗非非典型子宫内膜增生症的绝经后妇女方面取得的进展
1Department of Minimally Invasive Gynecologic Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Climacteric : the journal of the International Menopause Society
|August 14, 2023
概括
绝经后非典型的子宫内膜增生需要谨慎管理. 对大多数人来说,建议进行常规监测的保守治疗,但建议对高危人群进行子宫切除术.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 非典型子宫内膜质激增 (NAEH) 是一种良性疾病.
- 患有NAEH的绝经后妇女面临子宫内膜癌和持续性增生症的风险.
- 目前对于绝经后的NAEH的治疗策略仍在争论中.
研究的目的:
- 综合当前关于绝经后妇女NAEH病因,诊断和治疗的文献.
- 为临床决策提供最新的概述.
主要方法:
- 在PubMed数据库上进行全面的文献搜索,直到2022年12月.
- 专注于研究研究绝经后的NAEH的研究.
主要成果:
- 在NAEH中,缺乏显著的体质遗传改变.
- 对大多数绝经后的NAEH病例来说,保守的管理和定期的随访是合适的.
- 带有双边沙卵巢切除术的宫切除术是患有危险因素,持久性疾病或孕激素不耐受症的患者的首选选择.
结论:
- 及时诊断和适当的治疗对于预防NAEH进展至关重要.
- 对于患有NAEH的绝经后妇女,需要个性化治疗方法.
- 风险分层指导了保守管理和外科干预之间的选择.
更多相关视频
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.3K
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
相关概念视频
Menopause
201
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
201
Mitral Valve Prolapse III: Nursing Management
16
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
16
Hormonal Regulation of the Menstrual Cycle
438
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
438
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Mitral Valve Prolapse II: Assessment and Management
22
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
22
